Track the 제노레이 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 제노레이 has recorded 38 public disclosures. Market capitalisation: €43.2bn. The latest transaction was reported on 27 May 2026 (Other). Among the most active insiders: 박병욱. All data is free.
38
Insider Decl.
n/a
Thresholds
€10,111
28 ops.
Buy Volume
€45,054
2 ops.
Sell Volume
22Σ signal
Buys €10,111€45,054 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,959 of 28,016 companies
48.0
score / 100
Value
62
Quality
35
FCF yld8.8%
Earn yld1.7%
EV/EBITDA9.2x
ROE0.1%
Gross mgn39%
Net mgn0.7%
Debt/EBITDA4.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Genorey is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and commercialization of innovative pharmaceutical products.